Q&A with Pravin J. Mishra, PhD
Director, Research and Development Center
Intermountain Precision Genomics
MedicalLab Management: What are your laboratory’s therapeutic initiatives and goals, including the use of next generation sequencing?
Pravin Mishra: Intermountain Healthcare is internationally recognized as a highly regarded health care system, and in perpetuating this reputation, Intermountain initiated a precision medicine program to provide our patients with individualized cancer treatment. In order to deliver novel insights into the biology of disease, identify de novo targets, and benefit patients, our laboratory is motivated to interrogate new methodologies and technologies incorporating a bench-to-bedside approach (ie, research to clinic).
To read the full article, please log in or register.
ESR vs. CRP: Appropriate Test Utilization in Pediatric EDs and Urgent Care Clinics
Implementation of a Phlebotomy Career Ladder
Dispelling the 70% Claim with Laboratory's True Value
Improving CBC Utilization
Specimen Labeling & Tracking in the Ambulatory Setting
- In The Loop!
- Digital Edition
- Special Announcements